Apple, Biontech, ResMed Among Morning Market Cap Stock Movers on Wednesday
Wednesday’s market has seen notable fluctuations among stocks, with movements driven by various factors. Significant activity has been observed in the mega-cap and large-cap categories, with stocks such as Biontech Se (BNTX) and ResMed Inc (RMD) experiencing declines, while others like Apple (NASDAQ:AAPL), West Pharmaceutical Services Inc (NYSE:WST) and Super Micro Compu (SMCI) are on the rise. Here are some of the key stock movers today, from mega-caps to small caps.
Mega-Cap Movers
Apple (AAPL): Morgan Stanley would buy any estimate cuts: +1.9%
Large-Cap Stock Movers
Biontech Se (BNTX): -5.0%
ResMed Inc (RMD): Downgraded at Wolfe Research: -4.78%
NIO Inc (NIO): -4.53%
West Pharmaceutical Services Inc (WST): +4.95%
Super Micro Compu (SMCI): New Buy rating at Needham: +2.19%
Roku (NASDAQ:ROKU); Roku introduces self-service ad platform with Shopify (NYSE:SHOP) integration: +2.54%
Duolingo (DUOL): +3.46%
Mid-Cap Stock Movers
Bausch + Lomb (BLCO): up on continued takeover speculation: +8.49%
Casella Waste Sys (NASDAQ:CWST); Casella Waste Systems (CWST) Said To Offer Shares For $100-$102 Each – Bloomberg: -5.45%
Small-Cap Stock Movers
Applied Therapeutics Inc (NASDAQ:APLT); FDA proceeds with Applied Therapeutics’ govorestat review: +71.8%
Inflection Point Acquisition (LUNR); Intuitive Machines secures NASA cislunar network contract: +62.41%
XCHG Ltd ADR (XCH); XCharge, Asia Green Fund’s Portfolio, Successfully Listed on Nasdaq: +12.61%
Ivanhoe Capital Acquisition (SES): -13.27%
I.D. Systems (AIOT); Powerfleet to acquire Fleet Complete for $200 million: +10.52%
CF Acquisition Corp VI (RUMBW): -9.62%
Roman DBDR Tech Acquisition (CMPO); Resolute Holdings Completes Acquisition of Majority Interest in CompoSecure: +6.65%
Nano Nuclear Energy (NNE): -11.54%
Atlanticuss (ATLC): +8.49%
Byrna Technologies NAQ (BYRN): +6.93%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.